Skip to main content

The Mind-Body Enigma: Exploring Decoding Somatic Symptom Disorder

The Mind-Body Enigma: Exploring Decoding Somatic Symptom Disorder

Author
Kevin William Grant
Published
October 14, 2023
Categories

Explore the crossroads of mind and body with Somatic Symptom Disorder. Discover its evolution from historical myths to modern recognition.

Somatic Symptom Disorder (SSD) is a mental health condition featured in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). It is characterized by an excessive focus on physical symptoms, such as pain or fatigue, that leads to significant distress and impairment in daily functioning. Individuals with SSD often experience thoughts, feelings, and behaviors that revolve around their physical symptoms, and they might perceive them as very distressing, regardless of whether a medical cause can be found (American Psychiatric Association, 2013). They often express high levels of health-related anxiety and might excessively check their bodies, seek medical consultations frequently, or avoid activities due to fears or beliefs about their health. The intense focus is not purposefully produced or feigned, and the symptoms cause genuine distress.

The presentation can vary widely among individuals, but what remains consistent is the central role these symptoms play in the person's life and the emotional turmoil they produce. It is essential to differentiate SSD from other disorders where physical symptoms might be intentionally produced, like factitious disorders, or where the symptoms have a clear medical cause. The etiology of SSD is multifaceted, encompassing biopsychosocial factors. Psychological factors, past traumatic experiences, learning from family members or significant others, and certain personality traits might predispose individuals to develop this disorder (Dimsdale et al., 2013).

Diagnostic Criteria

Somatic Symptom Disorder (SSD) is a mental health condition described in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). Individuals with SSD have an extreme focus on physical symptoms, such as pain or fatigue, leading to significant distress or impairment in daily life. The diagnostic criteria for SSD are:

  • One or more somatic symptoms that are distressing or result in significant disruption of daily life.
  • Excessive thoughts, feelings, or behaviors related to the somatic symptoms or associated health concerns, manifested by at least one of the following:
  • Disproportionate and persistent thoughts about the seriousness of one's symptoms.
  • Persistently high level of anxiety about health or symptoms.
  • Excessive time and energy are devoted to these symptoms or health concerns.
  • The somatic symptoms are accurate and specific (e.g., localized pain) or relatively nonspecific (e.g., fatigue). However, they are not intentionally faked or produced.
  • Although any somatic symptom might not be continuously present, being symptomatic is persistent (typically more than six months).

It is essential to highlight that the focus is on the excessive nature of thoughts, emotions, and behaviors and not on the legitimacy of the somatic complaint. The exact cause of SSD remains a topic of investigation but is believed to stem from an interplay of genetic, biological, psychological, and environmental factors. Past trauma, heightened sensitivity to physical sensations, and negative experiences with healthcare professionals can contribute to developing and maintaining the disorder (Rief & Broadbent, 2007).

Somatic Symptom Disorder (SSD) is challenging to diagnose, primarily due to the complex interplay of physical symptoms and psychological factors. Here are some reasons why SSD is difficult to diagnose and other factors that need to be assessed:

  • Overlap with Medical Conditions: One of the primary challenges is the real presence of somatic symptoms. A patient may have genuine medical issues causing or exacerbating the symptoms. Distinguishing between symptoms resulting from a medical condition and those intensified by psychological factors can be challenging.
  • Variability of Symptoms: The physical complaints in SSD can vary widely, ranging from pain and fatigue to more specific complaints. This variability can make it hard to pinpoint SSD as the cause, especially when the symptoms mimic those of well-known medical conditions.
  • Patient's Perception: Patients with SSD often have a firm conviction about the severity of their symptoms. They may feel that healthcare professionals are not taking their concerns seriously, leading to frequent doctor visits, multiple tests, or even "doctor shopping" to find someone to validate their concerns.
  • Coexisting Mental Health Disorders: SSD can coexist with other mental health disorders like depression, anxiety, or other personality disorders. This comorbidity can complicate the clinical picture and make it harder to tease apart the root cause of the somatic complaints.
  • Cultural Differences: Perception and expression of physical symptoms can vary based on cultural backgrounds. In some cultures, expressing emotional distress through physical symptoms is more acceptable or common, which can be misconstrued as SSD.
  • History of Trauma: Past traumatic experiences can manifest later as physical symptoms. It is crucial to assess a patient's history to understand if past events might be contributing to current symptoms.
  • Differential Diagnosis: Other psychological disorders can also present with physical complaints. Illness anxiety disorder, conversion disorder, and factitious disorders are some conditions that can mimic SSD, making differential diagnosis crucial.
  • Patient's Reaction to Lack of Findings: Often, extensive medical tests yield no definitive findings. How a patient reacts to this—whether they find it reassuring or become more anxious and insistent on further testing—can offer clues about SSD.

A comprehensive assessment is essential for an accurate diagnosis. This includes a thorough medical evaluation to rule out or identify any medical conditions, a detailed psychiatric assessment, and often a multidisciplinary approach involving both medical and mental health professionals. Recognizing the complex interplay of mind and body in SSD is crucial for accurate diagnosis and effective treatment.

The Impacts

Somatic Symptom Disorder (SSD) can profoundly impact an individual's life, encompassing psychological and physical domains. The persistent and distressing nature of the symptoms often results in decreased overall functionality and well-being (Hiller et al., 2006).

Even though psychological factors might intensify the symptoms, the physical discomfort or pain experienced by the individual is genuine. This can lead to reduced energy, fatigue, and limitations in daily activities. Over time, excessive medical procedures or interventions, often sought out by the patient, can also pose risks and further physical complications.

Individuals with SSD often experience heightened anxiety levels, particularly related to health concerns. There is also an increased risk of comorbid mental health disorders like depression, anxiety, and other personality disorders (Kroenke, 2007). Their preoccupation with their health can lead to chronic feelings of distress, worry, and fear.

The constant focus on health can strain personal relationships. Family members might feel overwhelmed or uncertain about how to support the individual. There can be misunderstandings or frustrations if others perceive the concerns as exaggerated. Additionally, the individual might withdraw from social activities due to their symptoms or health anxieties, leading to increased isolation (Hiller et al., 2006).

Frequent medical visits and tests can result in substantial medical costs. Moreover, the individual's ability to work might be compromised, leading to decreased productivity, absenteeism, or even disability in severe cases (Kroenke, 2007).

Individuals with SSD often utilize healthcare services more than others, undergoing repeated tests and consultations in pursuit of answers and reassurance. This increases healthcare costs and can strain resources and divert them from others who might need them (Kroenke, 2007).

SSD is not merely a disorder of heightened health concerns. Its ripple effects touch various domains of an individual's life and can impact their immediate environment and the broader healthcare system.

The Etiology (Origins and Causes)

The etiology of Somatic Symptom Disorder (SSD) is multifaceted, encompassing a range of biopsychosocial factors contributing to its onset and persistence.

Biological Factors: Some theories posit that individuals with SSD may be sensitive to bodily sensations. This increased interoceptive awareness can lead them to detect and interpret normal bodily sensations as abnormal or distressing (Barsky et al., 2001). Genetic factors also play a role, with some research suggesting that individuals might inherit a predisposition to develop SSD or related disorders.

Psychological Factors: Early life experiences, particularly trauma or significant illness, can contribute to developing SSD. For instance, childhood physical or sexual abuse has been associated with an increased risk of somatic complaints in adulthood (Agras et al., 1969). Moreover, learning from family members or significant others who display illness behaviors can influence the perception and interpretation of bodily sensations. The tendency to catastrophize about health becomes a maladaptive coping strategy that can also predispose an individual to SSD (Rief & Broadbent, 2007).

Social and Cultural Factors: Cultural background can significantly influence how individuals perceive, interpret, and respond to physical symptoms. In some cultures, expressing emotional distress through somatic symptoms might be more prevalent or acceptable. Additionally, societal attitudes toward health and illness and the value placed on medical knowledge and intervention can shape individuals' perceptions and behaviors of their symptoms (Kirmayer & Young, 1998).

Past Medical History: Individuals who have experienced genuine medical conditions or have had prolonged encounters with the healthcare system might become more attuned to their bodily sensations. Misdiagnoses, negative experiences with healthcare providers, or prolonged periods without clear medical explanations can reinforce health anxieties and concerns (Barsky et al., 2001).

The etiology of SSD is intricately rooted in a combination of biological, psychological, and sociocultural factors. A comprehensive understanding of these contributing factors is crucial for effective diagnosis and intervention.

Comorbidities

Somatic Symptom Disorder (SSD) often does not exist in isolation; it frequently coexists with other psychological disorders, adding complexity to the clinical presentation. These coexisting disorders, or comorbidities, can intensify the symptoms and challenges associated with SSD.

One of the most common comorbidities with SSD is anxiety disorder. The heightened health concerns characteristic of SSD can manifest alongside generalized anxiety, creating a cycle where health anxieties fuel generalized anxiety and vice versa (Barsky et al., 2001). This interplay can complicate both the diagnosis and treatment of these conditions.

Depressive disorders are another significant comorbidity with SSD. Patients constantly focusing on their health and physical discomfort can feel hopeless and sad. Over time, these feelings can escalate into clinical depression, further exacerbating the distress experienced by these individuals (Kroenke et al., 1994).

Personality disorders, particularly the obsessive-compulsive and avoidant types, have also been observed in conjunction with SSD. The rigidity, perfectionism, and intense fear of serious illness found in some patients with SSD might align with traits from these personality disorders (Noyes et al., 1996).

In some instances, individuals with SSD might also present with other somatic symptom-related disorders, such as Illness Anxiety Disorder. While SSD emphasizes distress from physical symptoms, Illness Anxiety Disorder is characterized by high health anxiety in the absence of or disproportionate to any physical symptoms (American Psychiatric Association, 2013).

Given these comorbidities, a comprehensive assessment is essential when evaluating SSD. Recognizing and addressing these overlapping conditions can facilitate a more holistic treatment approach, ultimately improving patient outcomes.

Risk Factors

Somatic Symptom Disorder (SSD) is influenced by a constellation of risk factors predisposing individuals to develop and maintain the condition. Understanding these risk factors can aid in early identification and intervention.

  • Early Life Experiences: Childhood traumas, including physical, sexual, or emotional abuse, are robustly linked to developing SSD later in life (Roelofs & Spinhoven, 2007). Such traumas can shape an individual's perception of health and illness and their reactions to bodily sensations.
  • Family History: Growing up in an environment where family members frequently exhibit illness behaviors can be a model for children. This early learning might condition them to respond to stress or emotional distress with physical symptoms (Brown et al., 1990).
  • Personality Traits: Certain personality traits, such as neuroticism or heightened sensitivity to bodily sensations, can predispose individuals to develop SSD. A tendency toward pessimism or interpreting situations as threatening can amplify perceptions of physical discomfort (De Gucht & Fischler, 2002).
  • Previous Medical History: Having genuine medical conditions, especially if they have been chronic or poorly understood, can heighten an individual's focus on health. Repeated interactions with the healthcare system without receiving clear answers can foster health anxieties (Kroenke & Price, 1993).
  • Gender: While SSD can affect anyone, some studies indicate it might be more prevalent in women. Hormonal fluctuations, societal roles, or differences in health-seeking behaviors might contribute to this gender disparity (Fink et al., 1999).
  • Cultural and Social Factors: Cultural norms influence the expression and interpretation of emotional distress. In some cultures, manifesting emotional distress through physical symptoms might be more acceptable or prevalent (Kirmayer et al., 2004).
  • Coexisting Mental Health Disorders: Other mental health conditions, especially anxiety and depressive disorders, can increase the risk of developing SSD. These disorders might share common etiological factors with SSD or exacerbate its symptoms (De Waal, Arnold, Eekhof, & van Hemert, 2004).

These risk factors for SSD span a spectrum, from early life experiences to inherent personality traits and cultural influences. A multifaceted approach to understanding these factors can provide insights into prevention and targeted interventions.

Case Study

Patient: Josh, age 28.

Presenting Complaint: Josh presented with recurring chest pains and shortness of breath that he has experienced over the past ten months. He shared concerns about possibly having a severe heart condition, given that his father had undergone heart surgery in his late forties. Josh has consulted multiple cardiologists and undergone EKGs, stress tests, and echocardiograms, all showing no significant abnormalities.

History: Josh is an accountant and admitted that his job is often stressful. The initial onset of his chest pain was after a particularly demanding week at work, which included pulling several all-nighters. He first rushed to the ER, fearing a heart attack. Though medical evaluations were reassuring, Josh became increasingly preoccupied with his heart health.

Following the initial incident, Josh monitored his heart rate and blood pressure daily, frequently checking in with doctors at the slightest discomfort. He also started avoiding physical exertion, fearing it would strain his heart.

Social History: Josh lives with his girlfriend, who reports feeling overwhelmed by his persistent health anxieties. She mentioned that their social activities have reduced, as Josh often fears that certain activities might trigger another "episode." He has also taken numerous days off work due to his symptoms, impacting his professional growth.

Mental Health History: While Josh has no prior diagnosis of any psychiatric conditions, he did undergo counseling during college due to academic and relationship-related stress. He revealed that during those times, he would sometimes experience tension headaches.

Clinical Observations: Josh appeared anxious and frequently referenced a notebook documenting his daily symptoms, vitals, and food intake. He was visibly distressed when discussing his symptoms, emphasizing that "something is being missed" despite multiple doctors' reassurances.

Diagnosis: Based on the extensive medical assessments that found no cardiac issues, coupled with Josh's excessive preoccupation with his symptoms and the significant distress and disruption they have caused in his daily life, a diagnosis of Somatic Symptom Disorder (SSD) was made.

Treatment Recommendations: Josh was referred to cognitive-behavioral therapy (CBT) to address his health-related anxieties. The therapist would work with him to challenge and modify his catastrophic interpretations of his symptoms. Also, Josh was recommended to attend a support group for individuals with health anxieties to reduce his feelings of isolation and share coping strategies.

Recent Psychology Research Findings

Recent research in psychology has provided valuable insights into the understanding, assessment, and treatment of Somatic Symptom Disorder (SSD). A salient focus has been on cognitive processes underlying SSD. For example, studies have shown that individuals with SSD have a propensity for heightened attention to bodily sensations and a tendency to interpret these sensations in a catastrophizing manner (Rief et al., 2020). This cognitive bias can exacerbate their perception of symptoms, creating a feedback loop of anxiety and symptom attention.

Another emerging theme in SSD research revolves around neural underpinnings. Neuroimaging studies have discovered that individuals with SSD might have different patterns of brain activation when exposed to health-related cues or when processing pain. These differences suggest that there may be a neural basis for the heightened sensitivity and response to bodily sensations seen in SSD (Starr et al., 2019).

Therapeutically, cognitive-behavioral interventions remain a primary recommendation for SSD. However, recent studies have underscored the potential benefits of integrating mindfulness-based approaches. By teaching patients to observe their bodily sensations without judgment or reaction, mindfulness strategies can reduce the distress associated with these sensations and promote a more adaptive response (Lakhan & Schofield, 2013).

There is growing recognition of the need for culturally sensitive tools in assessment. Given that the interpretation and response to bodily sensations can vary widely across cultures, researchers advocate for developing and validating assessment tools that are culturally adapted, ensuring that SSD diagnoses are accurate and unbiased (Kirmayer et al., 2020).

In conclusion, the ongoing research on SSD is progressively refining our understanding of the disorder. From unraveling its cognitive and neural underpinnings to optimizing therapeutic interventions, these advancements promise to improve the lives of those affected by SSD.

Treatment and Interventions

Somatic Symptom Disorder (SSD) is a complex disorder requiring a holistic treatment approach. Various modalities have been explored in recent years, offering nuanced ways to address the intertwined psychological and physiological symptoms of SSD.

Cognitive-behavioral therapy (CBT) has emerged as a cornerstone in managing SSD. It zeroes in on the maladaptive thought patterns and behaviors often seen in patients with this condition. Through CBT, individuals learn to identify, challenge, and reframe these maladaptive thoughts, such as catastrophic interpretations of bodily sensations, shifting towards more balanced and rational perspectives (Kleinstäuber et al., 2011). For instance, a patient fearing that a headache indicates a tumor would be guided to consider more common and benign causes.

Mindfulness and Acceptance-Based Therapies, including Mindfulness-Based Stress Reduction (MBSR), have shown growing promise. Mindfulness-based therapies teach patients to approach their bodily sensations with a non-judgmental awareness. Instead of reacting to sensations with fear or avoidance, individuals learn to observe them objectively, diminishing the distress and anxiety these symptoms might otherwise provoke (Lakhan & Schofield, 2013).

While SSD is primarily a psychological condition, pharmacological interventions can sometimes be beneficial, mainly when there are comorbid conditions like depression or anxiety. Antidepressants such as SSRIs and SNRIs can help alleviate the mood and anxiety symptoms that often exacerbate SSD. However, it is essential that these medications be prescribed judiciously and be integrated into a broader treatment plan (Kroenke, 2007).

Patient Education is an often-underestimated component of SSD treatment. A comprehensive understanding of SSD can be empowering for patients. Knowing their symptoms are real but influenced by psychological factors can provide solace. Educational interventions might encompass relaxation techniques, graded exposure to feared situations, or strategies for acute symptom flares (van Dessel et al., 2014).

A unique challenge with SSD is the frequent seeking of medical evaluations. Here, the role of a trusted primary care physician becomes pivotal. Regular, structured check-ups can offer the reassurance these patients often seek while preventing unnecessary and costly medical investigations. This continuity of care fosters a trusting patient-doctor relationship, which is crucial in managing SSD (Smith et al., 2014).

With its intricate blend of physical and psychological symptoms, SSD necessitates a comprehensive, multifaceted treatment approach. Patients can significantly reduce symptom distress and improve their quality of life by integrating cognitive, behavioral, pharmacological, educational, and medical strategies.

Implications if Untreated

When Somatic Symptom Disorder (SSD) remains untreated, it can have profound ramifications on an individual's quality of life, both physically and psychologically. One of the most direct consequences of untreated SSD is persistent distress from the physical symptoms. Although not indicative of a medical illness, these symptoms can be debilitating, affecting daily functioning and overall well-being (Kroenke et al., 2002).

Beyond the immediate discomfort from the symptoms, these individuals often undergo many medical investigations in search of a diagnosis. Repeated tests, consultations, and sometimes unnecessary medical procedures can increase healthcare costs and potential medical complications. Moreover, despite these exhaustive medical evaluations, there needs to be a clear organic cause for the symptoms to leave individuals frustrated and invalidated (Barsky et al., 2005).

Psychologically, untreated SSD can lead to feelings of hopelessness, anxiety, and depression. Over time, the constant preoccupation with health and the potential seriousness of the symptoms can culminate in heightened health anxieties, further exacerbating the distress (Hiller et al., 2006). Additionally, these individuals might start avoiding certain activities or situations for fear of triggering or worsening their symptoms, leading to social isolation and decreased participation in previously enjoyed activities (Kroenke et al., 2002).

Relationships, too, can become strained. Family members and close friends might struggle to understand the persistent health concerns, especially without a precise medical diagnosis. Over time, these misunderstandings can result in tensions and a reduced support system for the individual (Jackson et al., 2006).

In summary, leaving SSD untreated can have cascading effects on an individual's physical health, psychological well-being, social interactions, and economic situation. Given these potential consequences, early identification and intervention are crucial to prevent exacerbating symptoms and associated distress.

Summary

Somatic Symptom Disorder (SSD) undoubtedly holds a unique and intricate position within psychiatric diagnoses. Historically, understanding disorders characterized by physical symptoms without clear medical etiology has undergone significant evolution. From being labeled as "hysteria" in the early days of psychoanalysis to being termed "somatization disorder" in more recent psychiatric classifications, the conceptualization of SSD reflects the intricate interplay between psychology, biology, and cultural factors (Stone, 2014).

The complex nature of SSD—where real physical symptoms coexist with psychological distress—makes it a challenging condition to diagnose accurately. Often, these individuals are caught in a revolving door of medical evaluations, searching for an organic cause of their distress. This iterative search frustrates patients and can lead to skepticism or even outright dismissal of their concerns in clinical settings (Dimsdale et al., 2017).

Today, while SSD has gained legitimacy as a diagnostic entity in the DSM-5, there still exists a debate in the broader medical community about the precise nature and legitimacy of the condition. This is partly due to its vast presentation spectrum, ranging from mild bodily misperceptions to debilitating physical symptoms that severely impact daily functioning. Recognizing SSD requires a holistic understanding that transcends traditional medical silos and acknowledges the profound mind-body interplay (Rief & Martin, 2014).

One of the pressing challenges in managing SSD is its treatment resistance. Traditional medical interventions often fall short, and even psychological interventions, though promising, do not guarantee success for every individual. This resistance underscores the necessity for continued research, exploring the underlying mechanisms of SSD and innovative treatment modalities to address its multifaceted nature (Kleinstäuber et al., 2011).

In summary, Somatic Symptom Disorder is a testament to the intricate dance between the mind and body. Its intricate history, diagnostic challenges, and the ongoing search for effective treatments make SSD a compelling area of exploration in the ever-evolving field of psychiatry.

 

 

References

Agras, S., Sylvester, D., & Oliveau, D. (1969). The epidemiology of common fears and phobia. Comprehensive Psychiatry, 10(2), 151-156.

Barsky, A. J., Ettner, S. L., Horsky, J., & Bates, D. W. (2001). Resource utilization of patients with hypochondriacal health anxiety and somatization. Medical Care, 39(7), 705-715.

Barsky, A. J., Orav, E. J., & Bates, D. W. (2005). Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Archives of General Psychiatry, 62(8), 903-910.

Barsky, A. J., Peekna, H. M., & Borus, J. F. (2001). Somatic symptom reporting in women and men. Journal of General Internal Medicine, 16(4), 266-275.

Brown, R. J., Golding, J. P., & Smith, G. R. (1990). Psychiatric morbidity in adult inpatients with childhood histories of sexual and physical abuse. The American Journal of Psychiatry, 147(1), 100-106.

De Gucht, V., & Fischler, B. (2002). Somatization: A critical review of conceptual and methodological issues. Psychosomatics, 43(1), 1-9.

De Waal, M. W., Arnold, I. A., Eekhof, J. A., & van Hemert, A. M. (2004). Somatoform disorders in general practice: prevalence, functional impairment and comorbidity with anxiety and depressive disorders. The British Journal of Psychiatry, 184(6), 470-476.

Dimsdale, J. E., Creed, F., Escobar, J., Sharpe, M., Wulsin, L., Barsky, A., ... & Levenson, J. (2013). Somatic Symptom Disorder: An important change in DSM. Journal of Psychosomatic Research, 75(3), 223-228.

Dimsdale, J. E., Sharma, N., & Sharpe, M. (2017). What do physicians think of somatic symptom disorders? A content analysis of amazon book reviews. Journal of Psychosomatic Research, 97, 97-101.

Fink, P., Sorensen, L., Engberg, M., Holm, M., & Munk-Jorgensen, P. (1999). Somatization in primary care: prevalence, health care utilization, and general practitioner recognition. Psychosomatics, 40(4), 330-338.

Hiller, W., Rief, W., & Brähler, E. (2006). Somatization in the population: from mild bodily misperceptions to disabling symptoms. Social Psychiatry and Psychiatric Epidemiology, 41(9), 704-712.

Jackson, J. L., Fiddler, S., Kapur, N., Wells, K., & Tomenson, B. (2006). Number of bodily symptoms predicts outcome more accurately than health anxiety in patients attending neurology, cardiology, and gastroenterology clinics. Journal of Psychosomatic Research, 60(4), 357-363.

Kirmayer, L. J., & Young, A. (1998). Culture and somatization: clinical, epidemiological, and ethnographic perspectives. Psychosomatic Medicine, 60(4), 420-430.

Kirmayer, L. J., Aggarwal, N. K., & Mazzotti, G. (2020). Cultural considerations in the understanding and assessment of somatic symptom disorder. Transcultural Psychiatry, 57(1), 3-26.

Kirmayer, L. J., Groleau, D., Looper, K. J., & Dao, M. D. (2004). Explaining medically unexplained symptoms. Canadian Journal of Psychiatry, 49(10), 663-672.

Kleinstäuber, M., Witthöft, M., & Hiller, W. (2011). Efficacy of short-term psychotherapy for multiple medically unexplained physical symptoms: A meta-analysis. Clinical Psychology Review, 31(1), 146-160.

Kroenke, K. (2007). Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosomatic Medicine, 69(9), 881-888.

Kroenke, K., & Price, R. K. (1993). Symptoms in the community: prevalence, classification, and psychiatric comorbidity. Archives of Internal Medicine, 153(21), 2474-2480.

Kroenke, K., Spitzer, R. L., & Williams, J. B. (2002). The PHQ-15: Validity of a new measure for evaluating the severity of somatic symptoms. Psychosomatic Medicine, 64(2), 258-266.

Kroenke, K., Spitzer, R. L., Williams, J. B. W., Linzer, M., & Hahn, S. R. (1994). Physical symptoms in primary care: predictors of psychiatric disorders and functional impairment. Archives of Family Medicine, 3(9), 774-779.

Lakhan, S. E., & Schofield, K. L. (2013). Mindfulness-based therapies in the treatment of somatization disorders: A systematic review and meta-analysis. PLoS ONE, 8(8), e71834.

Noyes, R., Holt, C. S., & Kathol, R. G. (1996). Somatic symptom disorders. In R. E. Hales, S. C. Yudofsky, & J. A. Talbott (Eds.), The American Psychiatric Press Textbook of Psychiatry (3rd ed., pp. 629-670). Washington, DC: American Psychiatric Press.

Rief, W., & Broadbent, E. (2007). Explaining medically unexplained symptoms-models and mechanisms. Clinical Psychology Review, 27(7), 821-841.

Rief, W., & Martin, A. (2014). How to use the new DSM-5 somatic symptom disorder diagnosis in research and practice: A critical evaluation and a proposal for modifications. Annual Review of Clinical Psychology, 10, 339-367.

Rief, W., Glombiewski, J. A., & Barsky, A. J. (2020). Psychological treatments for multiple somatic symptoms: A meta-analysis of randomized controlled trials. Psychotherapy and Psychosomatics, 89(1), 21-32.

Roelofs, K., & Spinhoven, P. (2007). Trauma and medically unexplained symptoms towards an integration of cognitive and neuro-biological accounts. Clinical Psychology Review, 27(7), 798-820.

Smith, R. C., Lyles, J. S., Gardiner, J. C., Sirbu, C., Hodges, A., Collins, C., ... & Goddeeris, J. (2014). Primary care clinicians treat patients with medically unexplained symptoms: A randomized controlled trial. Journal of General Internal Medicine, 19(5), 481-489.

Starr, C. J., Mennin, D. S., Luber, B., & Rubenstein, L. M. (2019). Altered fronto-limbic activity in somatic symptom disorder. Brain Imaging and Behavior, 13(3), 652-660.

Stone, L. (2014). Blurred lines: Somatic symptom disorders and the history of hysteria. British Journal of Psychiatry, 205(6), 491-492.

van Dessel, N., den Boeft, M., van der Wouden, J. C., Kleinstäuber, M., Leone, S. S., Terluin, B., ... & van der Horst, H. E. (2014). Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults. Cochrane Database of Systematic Reviews, 11, CD011142.

Post